Free Trial
OTCMKTS:TSNDF

TerrAscend 5/8/2025 Earnings Report

TerrAscend logo
$0.38 +0.04 (+10.29%)
As of 03:59 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$71.00 million
Expected Revenue
$71.63 million
Beat/Miss
Missed by -$630.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

TerrAscend to Host Second Quarter 2025 Earnings Conference Call
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
TerrAscend Announces Results of Annual General Meeting
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) is a diversified cannabis company engaged in the cultivation, processing and distribution of medical and adult-use cannabis products. Founded in 2015, the company has built operations in key North American markets, leveraging advanced cultivation technologies and proprietary genetics to deliver standardized flower, pre-rolls, concentrates and wellness formulations. Through its vertically integrated model, TerrAscend oversees each stage of the value chain, from greenhouse and indoor cultivation facilities to state-licensed dispensaries and wholesale partnerships.

In the United States, TerrAscend holds licensed operations in Illinois, Pennsylvania and Virginia, supplying both medical and recreational customers under a portfolio of branded offerings. Its flagship brands, including The Botanist™ and MagicMind™, feature curated flower and full-spectrum extracts, while the Flourish™ line focuses on wellness-oriented tinctures and topicals. In Canada, the company operates cultivation, processing and distribution facilities in Ontario and Quebec, serving adult-use consumers with premium dried flower and vape products. By tailoring its product mix to regional regulatory frameworks, TerrAscend aims to capitalize on evolving market dynamics and consumer preferences across jurisdictions.

Leadership at TerrAscend is led by Chief Executive Officer David Clement, who brings extensive experience in life sciences and CPG industries, having previously held senior roles at Amgen and Allergan. Under his guidance, the company has executed strategic acquisitions and organic expansions to strengthen its supply chain and retail footprint. The executive team also includes seasoned professionals in cultivation science, regulatory affairs and supply chain management, positioning TerrAscend to navigate complex compliance landscapes and scale operations efficiently.

As regulatory frameworks continue to evolve in North America, TerrAscend remains focused on innovation in product development, cultivation best practices and consumer engagement. By maintaining a disciplined approach to quality control, sustainability initiatives and brand building, the company strives to enhance shareholder value while addressing the needs of medical patients and adult-use consumers. Its presence in both established and emerging markets underscores a commitment to growth and leadership within the cannabis sector.

View TerrAscend Profile

More Earnings Resources from MarketBeat